Zhejiang Hisoar Pharmaceutical Co., Ltd. announced at the AGM held on May 13, 2022 that the company approved Cash dividend/10 shares (tax included) of CNY 1.00000000 for 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.75 CNY | +2.86% | +1.95% | -20.03% |
Apr. 18 | Hisoar Pharma's Unit Passes German Health Regulator's Inspection | MT |
Apr. 02 | Tranche Update on Zhejiang Hisoar Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.03% | 1.25B | |
+25.61% | 672B | |
+25.87% | 570B | |
-5.24% | 360B | |
+16.49% | 321B | |
+8.28% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- 002099 Stock
- News Zhejiang Hisoar Pharmaceutical Co., Ltd.
- Zhejiang Hisoar Pharmaceutical Co., Ltd. Approves Dividend for 2021